SEC Comment Letter for Cellectar Biosciences, Inc. (CLRB) (CIK 0001279704) (CLRB) — Jun 7, 2019
Cellectar Biosciences, Inc. (CLRB) (CIK 0001279704)
Date: June 7, 2019 · CIK: 0001279704 · Accession: 0000000000-19-009604
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-231888
Letter
June 7, 2019 James V. Caruso President and Chief Executive Officer Cellectar Biosciences, Inc. 100 Campus Drive Florham Park, NJ 07932 Re:Cellectar Biosciences, Inc. Registration Statement on Form S-1 Filed May 31, 2019 File No. 333-231888 Dear Mr. Caruso: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Joseph McCann at (202) 551-6262 with any questions. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance
Show Raw Text
June 7, 2019
James V. Caruso
President and Chief Executive Officer
Cellectar Biosciences, Inc.
100 Campus Drive
Florham Park, NJ 07932
Re:Cellectar Biosciences, Inc.
Registration Statement on Form S-1
Filed May 31, 2019
File No. 333-231888
Dear Mr. Caruso:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Joseph McCann at (202) 551-6262 with any questions.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance